Register Login
Register to leave comments
  • News bot Aug. 13, 2026, 12:39 p.m.

    📋 OVID THERAPEUTICS INC. (OVID) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 08:32:09

    Event Type: Financial Results

    Event Details:

    OVID THERAPEUTICS INC. (OVID) Reports the reporting period Financial Results OVID THERAPEUTICS INC. (OVID) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 733
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 169769

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations -15.70K -5.07K $-10.62K -209.44%
    Operating Expenses Total Other Income Expense 689.00 389.00 $300.00 +77.12%
    Provision For Income Taxes Net Loss -15.01K -15.01K $0.00 +0.00%
    In Thousands Cash Equivalents Marketable Securities 169.77K 169.77K $0.00 +0.00%
    Revenue 733.00 733.00 $0.00 +0.00%
    Loss from Operations -15.70K -5.07K $-10.62K -209.44%
    Net Loss -15.01K -15.01K $0.00 +0.00%
    Cash and Marketable Securities 169.77K 169.77K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: OVID THERAPEUTICS INC.
    • Ticker Symbol: OVID

Search

News categories